HLA-A*0201 | B2M | RHAMM-R3

HLA-A*0201 | B2M | RHAMM-R3

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Muparfostat sodiumPI-88Phase 3 ClinicalAustralian National University
Solid tumours; Liver Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Prostatic Neoplasms; Lung Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma
Details